Vaestra Goetalandsregionen — Sponsor Intelligence | 39 EU Trials

Filter these 39 trials by condition, phase, country and more.

Open in Search →

39 Registered trials

20 Recruiting

14 Completed trials

9 Countries active

66 Unique IMPs

100% Results reported

Phase III

Phase II

Phase IV

Phase III: 8 Phase II: 15 Phase I/II: 1 Phase IV: 12 Phase I (Other): 2 Phase I (FiH): 1

100%

14 of 14 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Acute myocardial infarction 1 Therapy cessation 1 Metastases to liver 1 Congenital myopathy 1 Uveal melanoma 1 Compulsive sexual behaviour 1 Triple negative breast cancer 1

Top IMPs

SODIUM CHLORIDE 3 NIVOLUMAB 2 2-(6-[18F]FLUORO-PYRIDIN-3-YL)-9H-DIPYRIDO[2,3-B:3',4'-D]PYRROLE 1 ADENOSINE 1 AFLIBERCEPT 1 ALDESLEUKIN 1 ANTI-T LYMPHOCYTE IMMUNOGLOBULIN FOR HUMAN USE, RABBIT 1 ANTITHYMOCYTE IMMUNOGLOBULIN 1 ARGIPRESSIN 1 BEVACIZUMAB 1 BUSULFAN 1 CAPECITABINE 1

All trials

39 total

The Swedish Nationwide Clinical Trial to Facilitate Patient Access to Targeted Cancer Treatment based on Biomarker Profiling (FOCU.SE) Pending

2024-516003-16-00 Phase II 1 country
Prevention of Sexual Offending with Cognitive Behavioral Therapy Alone Versus Therapy Combined with Testosterone Suppression – the PREVENT-M… Pending

2024-518120-68-01 Phase II 1 country
Evaluation of the clinical implementation of biofilm susceptibility to antibiotics using Minimum Biofilm Eradication Concentration (MBEC) in… Pending

2024-518350-17-00 Phase IV 1 country
Prognostic Performance of Quantitative Myocardial Perfusion Imaging Using H2[15O] Positron Emission Tomography in Coronary Artery Disease - … Pending

2024-518706-41-01 Phase III 1 country ADENOSINE; O15-WATER; REGADENOSON
Neoadjuvant pembrolizumab in patients with stage IIb/c melanoma, a phase II double-blind placebo-controlled randomized trial NEOPRIME Pending

2024-519594-19-00 Phase II 1 country PEMBROLIZUMAB; SODIUM CHLORIDE
Next generation StaR-TREC Pending

2025-522955-25-00 Phase IV 1 country CAPECITABINE
Evaluation of hANP for prevention of acute kidney injury after cardiac surgery: A two-part randomized controlled trial with open-label exten… Pending

2025-524069-26-00 Phase II 1 country CARPERITIDE
Anti-B-cell therapy in RA-ILD Recruiting

2025-524872-51-00 Phase IV 1 country
Discontinuation Outcome in Multiple Myeloma after BCMA-CD3 treatment Recruiting

2025-524022-18-00 Phase II 1 country ELRANATAMAB; TECLISTAMAB
Intra-articular corticosteroid injection vs arthrocentesis in the management of clinical arthritis of the temporomandibular joint: a randomi… Recruiting

2023-509114-11-00 Phase IV 1 country METHYLPREDNISOLONE ACETATE, LIDOCAINE HYDROCHLORIDE; PARACETAMOL; SODIUM CHLORID…
Digitoxin Pancreatic cancer trial-1 Recruiting

2024-512128-12-01 Phase II 1 country DIGITOXIN
PANCEP-1 Recruiting

2023-506979-10-00 Phase I/II 1 country ALDESLEUKIN; HISTAMINE DIHYDROCHLORIDE
A clinical phase IV trial to examine cellular and humoral immunity against measles and chickenpox in children and adolescents 0-18 years in … Recruiting

2024-511182-10-01 Phase IV 1 country
Phase III trial of lomustine/temozolomide (TMZ) combination therapy vs. standard TMZ therapy for newly diagnosed MGMT promoter methylated gl… Recruiting

2023-506998-35-00 Phase III 4 countries
STunning in Acute Myocardial Infarction – Beta blockers, Angiotensin converting enzyme inhibitors and Sodium/glucose cotransporter 2 inhibit… Recruiting

2024-511789-35-00 Phase IV 1 country
An open-label, non-randomised safety and tolerability Proof of Concept Trial to examine multiple dosing addition of glycocholate (GC) and bu… Recruiting

2024-511124-14-00 Phase I (FiH) 1 country SODIUM GLYCOCHOLATE, SODIUM BUTYRATE
NeuroPET GBG 001 - Mapping pathogenic processes associated with the development of neurodegenerative disorders using novel neuroimaging moda… Recruiting

2024-513499-16-00 Phase II 1 country 2-(6-[18F]FLUORO-PYRIDIN-3-YL)-9H-DIPYRIDO[2,3-B:3',4'-D]PYRROLE
CRA-TBE Recruiting

2023-509575-16-00 Phase IV 1 country TICK-BORNE ENCEPHALITIS VIRUS NEUDOERFL STRAIN ADSORBED ON ALUMINIUM HYDROXIDE, …
A Phase III Randomized Controlled Multicentre Trial of Percutaneous Hepatic Perfusion in Combination with Ipilimumab and Nivolumab Compared … Recruiting

2023-508156-20-00 Phase III 2 countries IPILIMUMAB; NIVOLUMAB
Use of Imatinib to convert triple negative breast cancer into ER-positive breast cancer - I-CONIC Recruiting

2024-511141-19-00 Phase II 1 country
Studying Conditioning Regimen In Pediatric Transplantation -AML Recruiting

2023-505512-37-00 Phase III 6 countries ANTI-T LYMPHOCYTE IMMUNOGLOBULIN FOR HUMAN USE, RABBIT; ANTITHYMOCYTE IMMUNOGLOB…
A randomized double-blind clinical trial comparing Hypochlorous Acid and Polyhexamethylene biguanide in treating diabetic foot ulcers Recruiting

2024-512612-22-00 Phase III 1 country
OPTION – OutPatienT InductiON: Labour induction in an outpatient setting - a multicentre randomized controlled trial Recruiting

2023-507164-39-00 Phase IV 1 country MISOPROSTOL
INTERCEPT Study Recruiting

2024-510615-29-00 Phase III 2 countries TOCILIZUMAB

Showing 1–24 of 39 trials

← All sponsors A–Z